Latest News about DSNKY

Recent news which mentions DSNKY

< Previous 1 2 Next >

FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer

June 24, 2025

AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients

April 21, 2025

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

March 21, 2025

FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients

January 28, 2025

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

January 21, 2025

After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer

December 06, 2024

Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients

September 23, 2024

Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study

September 17, 2024

AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial

September 10, 2024

DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q1 2024

August 13, 2024

Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10

August 07, 2024

Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast

July 30, 2024

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024

July 15, 2024

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug

June 27, 2024

Why Is AstraZeneca Stock Trading Lower On Tuesday?

May 28, 2024

DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q3 2023

April 30, 2024

Double Good News For AstraZeneca's Breast Cancer Drugs

April 29, 2024

AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor

April 08, 2024

What's Going On With Pfizer Stock Today?

January 25, 2024

Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today

January 03, 2024

Japan Emerges As Promising 2024 Investment Destination: 3 Stocks To Consider

December 20, 2023

Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?

October 31, 2023

Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting

September 22, 2023

AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials

September 11, 2023

FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt

July 21, 2023

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

July 04, 2023

AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial

July 03, 2023

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines

June 27, 2023

Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact

March 20, 2023

First Republic Bank sinks on possible sale reports, and Credit Suisse’s stock boosted by central bank borrowing

March 16, 2023

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.